Brooks Laboratories Limited, headquartered in Mumbai, India, is a leading pharmaceutical manufacturer and supplier operating both domestically and internationally. Established in 2002, the company specializes in the production and distribution of a wide range of pharmaceutical products, including carbapenem drugs, tablets, dry syrup, liquid and dry powder injections, as well as eye and ear drops. With a strong commitment to quality and customer satisfaction, Brooks Laboratories Limited continues to play a significant role in the healthcare industry.
Navigation section
Brooks Laboratories Limited
- 0.00 0.00(0.00%) 141.40 2.75(1.98%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 141.40 | 141.40 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 73.25 (05-Jun-2024) 72.51 (06-Jun-2024) | 185.70 (10-Jan-2024) 185.15 (10-Jan-2024) |
- Open
- 141.40
- Previous Close
- 138.65
- Volume
- 0.29
- Total Traded value
- 0.41 (₹ Lakhs)
- Upper circuit
- 141.49 205.70
- Lower circuit
- 135.94 137.20
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 0 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹3.71 Cr |
| PE Ratio (TTM): | 223.95 |
| PB Ratio: | 5.23 |
| Industry P/E: | 0.00 |
| Debt to Equity: | - |
| ROE: | 2.34 |
| EPS (TTM): | 0.62 |
| Book Value: | 0.00 |
| Face Value: | 10.00 |
Financials
| Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|
| Revenue | 15.70 Cr | 12.61 Cr | 12.00 Cr | 15.89 Cr |
| Profit | -0.53 Cr | -0.72 Cr | -2.08 Cr | -0.82 Cr |
| Expense | 16.29 Cr | 13.35 Cr | 14.15 Cr | 16.78 Cr |
| Comprehensive income | -0.53 Cr | -0.75 Cr | -2.08 Cr | -0.82 Cr |
| EPS | -0.22 | 0.29 | -1.68 | -0.33 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Brooks Laboratories Limited | Sep, 2011 Sep, 2011 | Pharmaceuticals Pharmaceuticals | BROOKS BROOKS |
Shareholding pattern
Sep, 2023 Aug, 2023 Jun, 2023 Mar, 2023 Dec, 2022
Brooks Laboratories Limited FAQ's
What is the range of today's stock performance for Brooks Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 0.00 on the NSE (National Stock Exchange) to a maximum of 0.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 141.40 to a high of 141.40.
What are the 52-week low and high values for Brooks Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 73.25 (occurred on 05-Jun-2024) and a high of 185.70 (achieved on 10-Jan-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 72.51 (on 06-Jun-2024), and the 52-week high is 185.15 (on 10-Jan-2024).
What was the opening and previous closing prices for Brooks Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 73.25 (occurred on 05-Jun-2024) and a high of 185.70 (achieved on 10-Jan-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 72.51 (on 06-Jun-2024), and the 52-week high is 185.15 (on 10-Jan-2024).
What is the total volume and traded value for Brooks Laboratories Limited for the day?
The total volume is 0, and the total traded value is 0.41 (₹ Lakhs).
What are the upper and lower circuit limits for Brooks Laboratories Limited?
The upper circuit limit is 141.49, and the lower circuit limit is 135.94.
What is the market cap and PE ratio for Brooks Laboratories Limited?
The market cap is ₹3.71 Cr, and the PE ratio (TTM) is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Brooks Laboratories Limited?
ROE is 2.34, EPS is 0.62, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Brooks Laboratories Limited?
In Jun 2023, Revenue is ₹157027000.00, and Profit is ₹-5327000.00. In Mar 2023, Revenue is ₹126141000.00, and Profit is ₹-7200000.00.
When was Brooks Laboratories Limited listed, and what industry does it belong to?
The company, Brooks Laboratories Limited, was listed in Sep 2011 and belongs to the Pharmaceuticals industry. Its NSE symbol is BROOKS.
What is the current shareholding pattern of the Brooks Laboratories Limited?
As of latest available update, promoters hold 63.59%, the public holds 36.41%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 95
